Since tumor organoids exhibited cellular structure similar to tumor tissue (Fig. 1d–f), we demonstrated that drug accessibility and uptake occurred in the deepest area at the core of tumor organoids, indicated by elevated γ-H2AX foci, a DNA damage response marker (Fig. S7). Here, H2AX is linked to neoplasm.